Gastroenterology News

Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.

New testing options for colorectal cancer will likely expand access to screening, but they are not as reliable as a colonoscopy, according to experts.

Children diagnosed with celiac disease and treated through a statewide screening program experienced improvements in initially unrecognized symptoms and quality of life, as well as greater adherence to a gluten-free diet, research showed.

The FDA has approved Geneoscopy Inc.’s ColoSense multitarget stool RNA test for adults aged 45 years or older at average-risk for developing colorectal cancer, according to a company press release.

A pharmacy-based, multicomponent intervention program reduced proton pump inhibitor use overall and also when appropriate for gastroprotection, with little evidence of either clinical harms or benefits, according to a study in BMJ.

Most children in three rural Alabama counties live without connections to centralized sewer systems, placing them at risk for certain infections, according to a study published in Pediatrics.

In a Healio video exclusive, Wendi LeBrett, MD, winner of the 2023 Healio Social Media Influencer Award, discusses how she uses social media, namely TikTok, to address misleading or inaccurate information about gastrointestinal diseases.

The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.

A regimen of pembrolizumab plus trastuzumab and chemotherapy extended OS for individuals with HER2-positive locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

In this exclusive Healio interview, Gideon Hirschfield, PhD, MB Bchir, the Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest insights into the gut microbiome’s role as a key player in disease development and progression.